Fierce Biotech December 22, 2023
Andrea Park

The science behind digital therapeutics may sound dubious on paper—a smartphone app that can help someone quit smoking, reverse Type 2 diabetes or treat depression?

In practice, however, these apps have held their own: Studies show that digital therapeutics from Better Therapeutics and Fitterfly can each significantly reduce blood sugar levels in people with Type 2 diabetes; video game-based technology developed by Akili can improve symptoms of ADHD, lupus and depression; and a virtual reality program from Luminopia could help treat lazy eye in kids.

In recent years, those promising study results have led to FDA approvals and clearances of the virtual technologies. Those commercial green lights, however, have largely failed to translate into profitability for makers of digital therapeutics,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, Technology
Search Funds growing interest in Healthcare Technology
The Hinge Health S-1 Breakdown
Executive Insights: 4 Key Takeaways from HIMSS and ViVE 2025
5 Digital Health Areas To Be Impacted By The FDA Layoffs
Telehealth regulations in Washington, D.C.: The most pressing need in policy

Share This Article